CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force

NEXT STORY
Camfil USA Update – Reduce Risk of Infectious Virus
PREV STORY
SIGA Announces Collaboration with Turnstone Biologics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tesaro Announces Participation at Two Investor Conferences

WALTHAM, Mass., Feb. 02, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News

Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC

WALTHAM, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven ...

author_avatar
NASDAQ Market News

nLife Therapeutics appoints Dr. Errol B. De Souza as Executive Chairman

GRANADA, Spain, June 1, 2016 (GLOBE NEWSWIRE) -- nLife Therapeutics, an early-stage biopharmaceutical company ...

author_avatar
NASDAQ Market News